Pharma Company Investment in Parenteral Manufacturing Capacity Picking Up

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-10-02-2004, Volume 28, Issue 10

Big Pharma is ramping up capital spending in parenteral manufacturing at the same time that contract manufacturers are completing their own major investment programs.

Related Content:

Drug DeliveryBio/Pharma BusinessOutsourcingManufacturingOutsourcing OutlookDevelopmentParenteralsDosage FormsManufacturing, Parenterals and InjectablesManufacturing, Drug ProductsPharmaceutical Technology-10-02-2004
INTERPHEX 2024: Implementing Contamination Control Strategies in Cell and Gene Therapy Facilities
Taking a Deeper Look at Sterile Powder Transfer in Aseptic Fill/Finish of Parenterals (INTERPHEX 2024)
Evaluating the Single-Use Trend in Pumping Systems for Fluid Handling (INTERPHEX 2024)